Pour plus de facilité, laissez cette case cochée. Sur les appareils partagés, nous vous conseillons de vous déconnecter d'Euroquity à la fin de votre utilisation
Email

Vous allez recevoir un email pour créer un nouveau mot de passe

Localisation

Choisissez votre pays

et votre langue

Bonjour ,

Bienvenue sur votre profil personnel. Votre carte de visite professionnelle présente votre activité principale. Elle sera visible sur EuroQuity.

% complété

%

medal 1
Ce profil est validé par 1 label.

Company

GeneQuine Biotherapeutics GmbH

GeneQuine Biotherapeutics GmbH_logo
19
EQ SCORE

L'EQ Score indique l'activité et l'attractivité de l'entreprise sur la plateforme : complétude du profil, actualités, likes, follows, appartenance à un ou plusieurs labels ou communautés, nombre de membres de son réseau, etc.

GeneQuine is a Hamburg, Germany-based biotech company focused on the development of gene therapy for musculoskeletal diseases.

Hamburg, Freie und Hansestadt, Hamburg, Germany

Send a message

Anglais

GeneQuine Biotherapeutics GmbH

Anglais

GeneQuine develops next generation gene therapy for musculoskeletal diseases with a potentially disease-modifying lead candidate for osteoarthritis.

In 2017, GeneQuine sold its (then-) lead program for osteoarthritis to Flexion Therapeutics Inc. for up to $64 million. 

GeneQuine is currently raising a series A of €16 million to take its second gene therapy drug candidate for osteoarthritis to the clinic, to start a development program for degenerative disc disease, and to expand its lab.

Team member(s)

Your request has been sent
Join this organization
Your request has been sent

Our network

Your request has been sent
Join this network
Your message has been sent

Certifications

High-Tech Gründerfonds
High-Tech Gründerfonds (HTGF) is a seed investor that finances high-potential, tech-driven startups. With 892.5 M€ in investment volume across three funds and an international network of partners, HTGF has already helped forge more than 530 startups since 2005. Its team of experienced investment managers and startup experts help guide the development of young companies. We focus on high-tech startups in software, media, internet, hardware, automation, health care, chemistry and life sciences.
15 Entities

Communities

InvestHorizon
InvestHorizon is an accelerator programme designed to facilitate the access to Series A funding for selected DEEP TECH companies.
2672 Members

Our history

Start in GeneQuine founded (2012)

  • GeneQuine founded (2012)

  • Proof-of-Concept (2014)

    Proof-of-Concept of disease-modifying gene therapy in osteoarthritis shown in large animal model

  • Lead program sold (2017)

    GeneQuine's lead program for osteoarthritis was acquired by Flexion Therapeutics for up to $64 M

  • R&D lab set up (2018)

    GeneQuine set up R&D labs in greater Berlin area.

to be continued ...